Education and Training
- General Nephrology Fellowship, Weill Cornell Medical College, 2001 - 2003
- Internal Medicine Residency, Weill Cornell Medical College, 1998 - 2001
- M.D., Duke University School of Medicine, 1998
- Ph.D., Duke University, 1995
Khosravi-Maharlooei, M, Hajizadeh-Saffar, E, Tahamtani, Y, Basiri, M, Montazeri, L, Khalooghi, K, Kazemi Ashtiani, M, Farrokhi, A, Aghdami, N, Sadr Hashemi Nejad, A, Larijani, M-B, De Leu, N, Heimberg, H, Luo, X, and Baharvand, H. "THERAPY OF ENDOCRINE DISEASE: Islet transplantation for type 1 diabetes: so close and yet so far away." European Journal of Endocrinology 173, no. 5 (November 2015): R165-R183. (Review)
Hlavaty, KA, Luo, X, Shea, LD, and Miller, SD. "Cellular and molecular targeting for nanotherapeutics in transplantation tolerance." Clinical Immunology (Orlando, Fla.) 160, no. 1 (September 2015): 14-23. (Review)
McCarthy, DP, Bryant, J, Galvin, JP, Miller, SD, and Luo, X. "Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells." American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15, no. 6 (June 2015): 1475-1483. (Review)
Senior, PA, Bellin, MD, Alejandro, R, Yankey, JW, Clarke, WR, Qidwai, JC, Schwieger, TR, Eggerman, TL, Robien, MA, and Rickels, MR. "Consistency of Quantitative Scores of Hypoglycemia Severity and Glycemic Lability and Comparison with Continuous Glucose Monitoring System Measures in Long-Standing Type 1 Diabetes." Diabetes Technology & Therapeutics 17, no. 4 (April 2015): 235-242.
Wang, S, Zhang, X, Zhang, L, Bryant, J, Kheradmand, T, Hering, BJ, Miller, SD, and Luo, X. "Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection." Cell Transplantation 24, no. 6 (January 2015): 1155-1165.
Bryant, J, Hlavaty, KA, Zhang, X, Yap, W-T, Zhang, L, Shea, LD, and Luo, X. "Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation." Biomaterials 35, no. 31 (October 2014): 8887-8894.
Hlavaty, KA, Gibly, RF, Zhang, X, Rives, CB, Graham, JG, Lowe, WL, Luo, X, and Shea, LD. "Enhancing human islet transplantation by localized release of trophic factors from PLG scaffolds." American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 14, no. 7 (July 2014): 1523-1532.
Bryant, J, Lerret, NM, Wang, J-J, Kang, H-K, Tasch, J, Zhang, Z, and Luo, X. "Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection." Journal of Immunology (Baltimore, Md. : 1950) 192, no. 12 (June 2014): 6092-6101.
Lerret, NM, and Luo, X. "IL-15 expanded CD8+CD122+ cells: when do they suppress?." American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 14, no. 1 (January 2014): 7-8.
Wang, S, Tasch, J, Kheradmand, T, Ulaszek, J, Ely, S, Zhang, X, Hering, BJ, Miller, SD, and Luo, X. "Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T- and B-cell tolerance to islet xenografts." Diabetes 62, no. 9 (September 2013): 3143-3150.